High antibiotic consumption for the treatment of bacterial and viral infections in recent decades has resulted in a failure of their efficacy. The number of recurrent bacterial infections suffered by the general population in which the antibiotic is not effective (derived from resistance) is increasing every day, and bacterial immunotherapy plays a very important role in the prevention and prophylaxis of future bacterial infections.
Antibiotic treatment failure derived from resistance leads to preventive therapies: Bacterial Immunotherapy.
The treatment of recurrent bacterial infections with bacterial immunotherapy is an individualised prophylactic treatment which represents an alternative to antibiotic treatment, and an effective measure in the prevention of recurrent bacterial infections (tonsillitis, sinusitis, pharyngitis, bronchitis, cystitis, prostatitis, etc.).
Bacterial vaccines can be classified according to the source of the sample as either auto-vaccines or polybacterial vaccines.
Auto-vaccines are created based on the isolation, culture and inactivation of the strains of bacteria isolated from the patient's sample, and represent an effective prophylactic therapy in the individualised treatment of recurrent bacterial infections.
On the other hand, a polybacterial vaccine is manufactured from the collection of bacterial strains selected by the specialist, based on the bacterial agent causing the condition in question.
There are two types of presentations available on the market:
These presentations facilitate treatment compliance by the patient.
Individualised treatment for the prevention of recurrent bacterial infections.